Aspirin resistance mediated by oxidative stress-induced 8-Isoprostaglandin F2.
J Clin Pharm Ther
; 44(5): 823-828, 2019 Oct.
Article
de En
| MEDLINE
| ID: mdl-30989683
ABSTRACT
WHAT IS KNOWN AND OBJECTIVE:
Aspirin resistance refers to a patient's poor response to aspirin. There are many factors that can contribute to aspirin resistance, including single-nucleotide polymorphisms, medication compliance, drug-drug interactions and inflammation.COMMENT:
Recently, oxidative stress-induced 8-isoprostaglandin F2α has attracted considerable attention because it is considered as a mechanism of aspirin resistance in many diseases, including coronary artery disease, neurology system disease, metabolic syndrome, cancer, chronic obstructive pulmonary disease and chronic kidney disease. In these diseases, increased oxidative stress may promote platelet activation and reduce the efficacy of aspirin by producing excessive amounts of 8-isoprostaglandin F2α. WHAT IS NEW ANDCONCLUSION:
Given the wide clinical use of aspirin, it is essential to understand why some patients do not response to it. This article reviews current research on aspirin resistance mediated by oxidative stress-induced 8-isoprostaglandin F2α.Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Résistance aux substances
/
Dinoprost
/
Acide acétylsalicylique
/
Stress oxydatif
Limites:
Humans
Langue:
En
Journal:
J Clin Pharm Ther
Sujet du journal:
FARMACIA
/
TERAPEUTICA
Année:
2019
Type de document:
Article
Pays d'affiliation:
Chine